PMA device
GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1
W. L. Gore & Associates, Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment (MIH, Class III) · First FDA decision Mar 23, 2005, newest Jul 13, 2026Aortic aneurysm and dissection
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
17
Breakthrough-designated
Device trials
22
Naming "GORE TAG Thoracic"
MAUDE reports
30
Brand "GORE TAG Thoracic", since 2015
PubMed studies
75
Mentioning "GORE TAG Thoracic"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 17 decisions filed under this name.
- GORE® TAG® Thoracic Branch Endoprosthesis Zone 0/1PMA supplement
P210032-S026 · Decided Jul 13, 2026 · 31 days after receipt · Normal 180 Day Track No User Fee
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- GORE TAG Thoracic Branch Endoprosthesis (TBE Device)PMA supplement
P210032-S019 · Decided Aug 21, 2025 · 104 days after receipt · Normal 180 Day Track No User Fee
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
- GORE TAG Thoracic Branch Endoprosthesis (TBE Device)BreakthroughPMA supplement
P210032-S007 · Decided May 2, 2023 · 84 days after receipt · Normal 180 Day Track
Device type: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT (MIH) · Cardiology
3 more FDA decisions with a free account
Older decisions: P040043-S106, P040043-S067, P040043-S051, P040043-S040, P040043-S039, P040043-S037, P040043-S031, P040043-S023, P040043-S019, P040043-S006, P040043
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "GORE TAG Thoracic", any status and sponsor, newest update first.
W.L.Gore & AssociatesNot on our public-company list
NCT07166133 · 125 participants (planned) · Start Mar 2, 2026 · Primary completion Jul 2028
Device: GORE® TAG® Thoracic Branch Endoprosthesis · For: Aortic Arch Dissection; Aortic Arch Aneurysm
Sites: Scottsdale, Arizona; Los Angeles, California; Palo Alto, California · 25 sites in all
- Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 0/1Active, not recruiting
W.L.Gore & AssociatesNot on our public-company list
NCT02777528 · 79 participants · Start Aug 2016 · Primary completion Mar 2024
Device: GORE® TAG® Thoracic Branch Endoprosthesis · For: Aortic Aneurysm, Thoracic; Aorta, Lesion
Sites: Los Angeles, California; Stanford, California; Hartford, Connecticut · 39 sites in all
- Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2Active, not recruiting
W.L.Gore & AssociatesNot on our public-company list
NCT02777593 · 250 participants · Start Sep 6, 2016 · Primary completion Apr 12, 2021
Device: GORE® TAG® Thoracic Branch Endoprosthesis · For: Aortic Aneurysm, Thoracic; Aorta; Lesion
Sites: Los Angeles, California; Stanford, California; Hartford, Connecticut · 35 sites in all
19 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GORE TAG Thoracic", and for the whole product code for context.
This brand
30 reports: 3 malfunction, 24 injury, 3 death
Whole product code MIH
43,674 reports: 7,807 malfunction, 32,331 injury, 3,518 death
Newest reports for this brand
- GORE TAG THORACIC BRANCH ENDOPROSTHESISMalfunction
22148693 · Received Jun 5, 2025 · Event dated May 22, 2025
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Device problem as coded: Difficult to Advance; Material Twisted/Bent; Activation Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
21282689 · Received Jan 31, 2025 · Event dated Nov 6, 2024
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Patient problem as coded: Diminished Pulse Pressure; Reduced Blood Flow
- GORE TAG THORACIC BRANCH ENDOPROSTHESISMalfunction
20255594 · Received Sep 19, 2024 · Event dated Mar 25, 2024
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2672-2026 · Started May 19, 2026 · Posted by FDA Jul 2, 2026
Reason given: Due to catheter separation
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Z-0290-2021 · Started Sep 9, 2020
Reason given: Due to secondary deployment fiber being attached to secondary deployment handle, completion of deployment via the deployment line access hatch was not possible
Cause as FDA categorized it: Unknown/Undetermined by firm · Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Z-0291-2021 · Started Sep 9, 2020
Reason given: When the delivery catheter was attempted to be removed, there was an observed connection between the stent graft and the delivery catheter that prevented the delivery catheter from being withdrawn.
Cause as FDA categorized it: Process control · Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
4 more recall records with a free account
Published research
The most relevant PubMed records for "GORE TAG Thoracic"[tiab]. The summary above synthesizes these.
- Gore Tag Thoracic Branch Endoprosthesis in Acute Aortic Syndromes: A Case Series.
Spertino A, Marrocco S, Zavatta M, et al. · J Endovasc Ther · 2025
- Conformable GORE TAG thoracic endoprosthesis.
Morasch MD · Expert Rev Cardiovasc Ther · 2014Review
- Gore TAG thoracic branch endograft for treatment of a subacute type B aortic dissection complicated by rupture.
Pitcher GS, Newhall KA, Stoner MC, et al. · J Vasc Surg Cases Innov Tech · 2023Case Reports
- Early experience with the Gore TAG thoracic branch endoprosthesis for treatment of acute aortic pathology.
DiLosa K, Pozolo C, Heafner T, et al. · J Vasc Surg Cases Innov Tech · 2024
- GORE TAG Thoracic Endograft with Active Control System: Landing Accuracy and Wall Apposition in an Initial Clinical Experience.
Antonello M, Squizzato F, Dall'Antonia A, et al. · Ann Vasc Surg · 2019
- Initial Outcomes of the Gore TAG Thoracic Branch Endoprosthesis for Endovascular Repair of Blunt Thoracic Aortic Injury.
Chou EL, Lu E, Dake MD, et al. · Ann Vasc Surg · 2024Multicenter Study
- Dissecting Into the 2021 Chest Pain Guidelines.
Dong T, Jaber WA · JACC Case Rep · 2022Case Reports
- The GORE(®) TAG(®) thoracic endoprosthesis.
Vallabhaneni R, Farber MA · Expert Rev Med Devices · 2013Review
- First Use of GORE TAG Thoracic Endograft with Active Control System in Traumatic Aortic Rupture.
Eforakopoulos F, Akrida I, Zampakis P, et al. · Case Rep Surg · 2020Case Reports
- Gore TAG Thoracic Endoprosthesis: the first US FDA-approved thoracic endograft.
Diethrich EB · Expert Rev Med Devices · 2006
- Midterm outcome in 158 consecutive Gore TAG thoracic endoprostheses: single center experience.
Wheatley GH, Gurbuz AT, Rodriguez-Lopez JA, et al. · Ann Thorac Surg · 2006Clinical Trial
- Evaluation of the Gore TAG thoracic branch endoprosthesis in the treatment of proximal descending thoracic aortic aneurysms.
Dake MD, Fischbein MP, Bavaria JE, et al. · J Vasc Surg · 2021Multicenter Study
Other devices of this type
Also filed under product code MIH.
- Ancure Endograft SystemBoston Scientific Corp · PMA 2003
- Aneurx Stent Graft SystemMedtronic Vascular · PMA 2011
- Talent Thoracic Stent Graft SystemMedtronic Vascular · PMA 2016
- GORE EXCLUDER AAA Endoprosthesis product familyW. L. Gore & Associates, Inc. · PMA 2021
- Talent Abdominal Stent Graft SystemMedtronic Vascular · PMA 2014
- TREO® Abdominal Stent-Graft SystemBolton Medical, Inc. · PMA 2026
- Zenith Fenestrated AAA Endovascular GraftCook, Inc. · PMA 2022
- Powerlink System with Intuitrak Delivery SystemEndologix, LLC · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.